Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age - Concepedia

Concepedia

Publication | Open Access

Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age

DOI Full Paper Access

40

Citations

56

References

2021

Year

Matt Wasserman, Johnna Perdrizet, Lindsay R. Grant, Kyla Hayford, Shubhra Singh, P Saharia, Emily K. Horn, Raymond Farkouh

Infectious Diseases and Therapy

Abstract

Despite the success of PCV10 and PCV13 in reducing pneumococcal disease, a substantial clinical and economic burden remains due to serotypes contained in investigational vaccines.

References

	Year	Citations

Page 1